SWOG Cancer Research Network, shared a post on X about a recent clinical trial:
“Clinical Trial S2312 tests a combination of chemo drugs for castrate-resistant prostate cancer.
Participants receive tumor testing to find out if their cancer is aggressive variant prostate cancer.
Visit swog.org or call 1-800-4-CANCER.”
More posts featuring prostate cancer on OncoDaily.